Posted inPharmaceutical
My Investment Portfolio
November 21, 2024 position BIL 91.97% FF 2.01% BKNG 2.30% CASH 3.72% The position in BIL is very large. I'm satisfied with the return from BIL because I can sleep…
Posted inFood Pharmaceutical
Abbott(ABT) 2023 Financial Analysis and Stock Valuation
Introduction Abbott has four reportable segments: Established Pharmaceuticals, Diagnostics, Nutritional Products, and Medical Devices. Asset Structure Analysis Abbott’s total assets were $73.2 billion as of December 31, 2023, down from…
Posted inPharmaceutical
Viatris(VTRS) 2023 and Q1 2024 Financial Analysis, and Stock Valuation
Asset Structure Analysis Viatris’ total assets were $47.7 billion as of December 31, 2023, down from $50 billion as of December 31, 2022. Intangible assets, net were $19.2 billion as…
Posted inPharmaceutical
Phibro Animal Health(PAHC) 2023 and Q3 2024 Financial Analysis, and Stock Valuation
Assets structure analysis Phibro Animal Health’s total assets were $971.4 million and $931.7 million as of June 30, 2023 and June 30, 2022, respectively. As of June 30, 2023, the…
Posted inPharmaceutical
Pfizer(PFE) 2023 Financial Analysis and Stock Valuation
Assets condition analysis Pfizer’s total assets were $226.5 billion as of December 31, 2023, a increase of 14.9%, compared with $197.2 billion as of December 31, 2022. Identifiable intangible assets…
Posted inPharmaceutical
Bristol-Myers Squibb(BMY)Q1 2024
At April 25, 2024, Bristol-Myers Squibb released quarterly report for quarter ending march 31, 2024. Bristol-Myers Squibb’s total revenues were $11.9 billion and $11.3 billion in Q1 2024 and Q1…
Posted inPharmaceutical
Teva pharmaceutical(TEVA) 2023 Financial Analysis and Stock Valuation
Asset structure analysis Teva pharmaceutical ‘s total assets were $43.5 billion and $44 billion at December 31, 2023 and at December 31, 2022, respectively. Goodwill was $17.2 billion as of…
Posted inPharmaceutical
Biogen(BIIB):Analysis of Financial Statement for 2022 and for Q3 2023
Introduction Biogen(BIIB) is a global biopharmaceutical company focused on discovering, developing and delivering innovative therapies for people living with serious and complex diseases worldwide. Biogen(BIIB) have a broad portfolio of…
Posted inPharmaceutical
Sanofi(SNY): financial analysis for 2022 and Q3 2023.
Summary We reckon Sanofi(SNY) is worth €115 billion or $125.3 billion. Introduction Sanofi(SNY) is a leading global healthcare company, focused on patient needs and engaged in the research, development, manufacture…
Posted inPharmaceutical
Bristol-Myers Squibb Company(BMY)：$50 per share is a good buying opportunity
Bristol-Myers Squibb(BMY)Q1 2024 Introduction Bristol-Myers Squibb Company(BMY) continues to operate in one segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global…